Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$318.29 - $392.21 $11.1 Million - $13.6 Million
34,766 New
34,766 $12.2 Million
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $738,732 - $1.03 Million
3,002 Added 23.68%
15,678 $3.86 Million
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $738,732 - $1.03 Million
3,002 Added 23.68%
15,678 $3.86 Million
Q2 2022

Aug 15, 2022

BUY
$280.61 - $420.45 $3.56 Million - $5.33 Million
12,676 New
12,676 $3.83 Million
Q1 2022

May 16, 2022

SELL
$357.49 - $445.92 $341,402 - $425,853
-955 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$402.25 - $471.34 $1.01 Million - $1.18 Million
-2,507 Reduced 72.41%
955 $448,000
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $447,228 - $577,155
1,232 Added 55.25%
3,462 $1.47 Million
Q2 2021

Aug 16, 2021

BUY
$284.77 - $363.2 $635,037 - $809,936
2,230 New
2,230 $801,000
Q3 2020

Nov 16, 2020

SELL
$224.99 - $288.02 $2.06 Million - $2.64 Million
-9,158 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$149.8 - $227.17 $1.26 Million - $1.9 Million
8,379 Added 1075.61%
9,158 $2.08 Million
Q1 2020

May 15, 2020

BUY
$128.96 - $174.76 $100,459 - $136,138
779 New
779 $119,000
Q4 2019

Feb 14, 2020

SELL
$137.6 - $151.21 $357,347 - $392,692
-2,597 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $64,104 - $79,210
528 Added 25.52%
2,597 $368,000
Q2 2019

Aug 14, 2019

BUY
$111.27 - $125.15 $217,421 - $244,543
1,954 Added 1699.13%
2,069 $259,000
Q1 2019

May 15, 2019

BUY
$94.53 - $110.2 $10,870 - $12,673
115 New
115 $13,000
Q1 2018

May 15, 2018

SELL
$85.56 - $102.4 $7,614 - $9,113
-89 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$91.65 - $101.65 $8,156 - $9,046
89
89 $9,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.